SMALL MOLECULES FOR ADOPTIVE T-CELL THERAPY (ACT) THROUGH ACTIVATION OF THE mTOR SIGNALLING PATHWAY, PROCESS FOR PREPARTION THEREOF

WO2024236589A1PCT designated stage expired Publication Date: 2024-11-21COUNCIL OF SCI & IND RES

Patent Information

Application Number
PCT/IN2024/050437
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-18
Filing Date
2024-04-24
Publication Date
2024-11-21

Smart Images

  • Figure IN2024050437_21112024_PF_FP_ABST
    Figure IN2024050437_21112024_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to the preparation of 8-phenyl-purine-6-amino compounds with general structure I in free form or in acceptable salt form to identify small molecule activator of mTOR, which can be used to augment the effector function (IFNγ production) of T cells and hence heightened their antitumor response. More particularly, the invention relates to small molecules where R1, R2 and R3 are as defined in the description, capable of IFNγ production via mTOR activation pathway to elicit durable antitumor repose in the host. The invention describes strategies to generate T cells with high effector function, yet in a relatively short period of time so that a robust and durable anti-tumor response can be achieved in the host.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Imidazopyridine compounds, compositions and methods of use

    WO2011113802A2

Cited By

  • Targeted therapy of cancer by pharmacological activation of mtor

    WO2026125700A1